PUMA BIOTECHNOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
PUMA BIOTECHNOLOGY, INC. (PBYI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $1.08 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2021-11-04
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.08M.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $2.53M.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $2.99M.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $3.46M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2021-09-30 | $1.08M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.53M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.99M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.46M 10-Q · filed 2021-11-04 |
| 2020-09-30 | $3.35M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.72M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.97M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.95M 10-K · filed 2021-03-01 |
| 2019-09-30 | $2.45M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $3.43M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $25.92M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $7.76M 10-K · filed 2021-03-01 |
| 2018-09-30 | $38.86M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $72.37M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $100.13M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $220.06M 10-K · filed 2021-03-01 |
| 2017-09-30 | $318.35M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $189.48M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $26.58M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $18.44M 10-K · filed 2020-02-28 |
| 2016-09-30 | $79.72M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $17.67M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $17.19M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $87.63M 10-K · filed 2019-03-01 |
| 2015-09-30 | $80.26M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $176.73M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $513.72M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $431.63M 10-K · filed 2018-03-09 |
| 2014-09-30 | $699.38M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $115.73M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $214.36M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $208.90M 10-K · filed 2017-03-01 |
| 2013-09-30 | $90.33M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $72.66M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $48.29M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $18.97M 10-Q · filed 2013-11-12 |
| 2012-09-30 | $13.82M 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |